Almost half of the all Americans and Europeans died of coronary artery disease in the last half of the 1990’s. The pharmaceutical industry literally makes billions of dollars a year promoting and selling their statin drugs as the solution to this heart disease. However, researchers and doctors are just beginning to realized that statins are not the solution. As an example, James Wright, MD university professor and Director of Canada’s Therapeutic Initiative, in analyzing the data on lipid lowering drugs came to this conclusion: No benefit in people over the age of 65, no matter how much their cholesterol declines, and no benefit in women of any age. There was a small reduction in the number of heart attacks for middle-aged men taking statins in clinical trials. But even for these men, there was no overall reduction in total deaths or illnesses requiring hospitalization. He concluded, Most people are taking something with no chance of benefit and a risk of harm. How long will it take the medical community to come to the realization that statins have limited if any benefit in treating heart disease? Because of the huge profits that are being reaped from selling these drugs probably a long time. Terry Pfau DO, HMD